Form 4 for CELU Celularity Inc
Accepted 2023-04-17 00:00:00 ET · period of report 2023-04-13 · accession 0000899243-23-011344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | 2023-04-13 | CELU | Fletcher Kyle | See Remarks | F - Tax | $0.71 | -201 | 256.8K | -0.1% | -$142.71 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-04-13 | F | D | 201 | $0.71 | 256,799 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy its tax withholding obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale. (F2) Includes 249,462 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting. |